Covid-19 roundup: JA­MA study says peo­ple 65+ like­ly ex­clud­ed from tri­als; Trump plans roll­out of 150 mil­lion rapid tests

A new study pub­lished in JA­MA In­ter­nal Med­i­cine on Mon­day as­serts that de­spite mak­ing up the vast ma­jor­i­ty of Covid-19 deaths, in­di­vid­u­als old­er than 65 are high­ly like­ly to be ex­clud­ed from clin­i­cal tri­als for vac­cines and treat­ments.

Re­searchers looked at 847 Covid-19 stud­ies post­ed on the US gov­ern­ment’s clin­i­cal tri­als di­rec­to­ry be­tween Oct. 1, 2019 and June 1 of this year. They de­ter­mined that this age pop­u­la­tion is like­ly to be left out of more than half of all tri­als, as well as 100% of vac­cine tri­als.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER